Treatment with cediranib or cediranib plus olaparib is not superior to standard of care (SOC) in patients with platinum-resistant or -refractory epithelial ovarian cancer, according to results from a ...

(HealthDay News) — Overall survival (OS) after umbilical cord blood transplant (UCBT) has improved over time, according to a study published in Transplantation and Cellular Therapy.

The Healgen at-home test is the first OTC test for influenza detection to be granted marketing authorization outside of an emergency use authorization.

Data suggest that uptake of colorectal cancer screening increased after the USPSTF issued a recommendation that all average-risk individuals aged 45 to 49 years should undergo screening.

In a randomized trial, transperineal and transrectal approaches to prostate biopsies offered similar rates of cancer detection, but transrectal biopsy was associated with a significantly higher ...

Phase 2 data support the feasibility of administering liso-cel in the community setting with outpatient monitoring in appropriate patients.

The Dependent Care Expansion of the ACA may have improved survival outcomes among cancer patients aged 19-25 years.

Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults age 45 years and older who are at average risk of colorectal cancer.

Gender-affirming hormone therapy may reduce the risk of prostate cancer in transgender women, but it may also increase the risk of biochemical recurrence and bone metastases in patients with prostate ...

Female physicians remain underrepresented among residents entering high-compensation specialties, data suggest.

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...